Treatment Of Sickle Cell Disease
Type
PatentPatent Status
Granted Patent
KAUST Department
Computational Bioscience Research Center (CBRC)Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division
Applied Mathematics and Computational Science Program
Date
2014-12-04Submitted Date
2014-06-23Permanent link to this record
http://hdl.handle.net/10754/595349Metadata
Show full item recordAbstract
The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.Patent Number
US 9655905 B2US 10085967 B2
Application Number
US 20140356458 A1WO 2013057592 A2
WO 2013057592 A3
US 20170209412 A1
Additional Links
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220140356458%22.PGNR.&OS=DN/20140356458&RS=DN/20140356458http://assignment.uspto.gov/#/search?adv=publNum:20140356458
http://www.google.com/patents/US20140356458
http://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=2014356458A1&KC=A1&FT=D
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=%22Bajic+Vladimir%22.INNM.&OS=IN/%22Bajic+Vladimir%22&RS=IN/%22Bajic+Vladimir%22
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=7&f=G&l=50&co1=AND&d=PTXT&s1=%22Bajic+Vladimir%22.INNM.&OS=IN/%22Bajic+Vladimir%22&RS=IN/%22Bajic+Vladimir%22